The expression levels of eNOS are altered in patients with various pathophysiological conditions, such as cardiovascular disease, atherosclerosis, diabetes mellitus, and hypertension (Chatterjee et al. 2008). The gene discussed is NOS3; the disease is cardiovascular disorder.